Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.
Surgery. 2024 Mar;175(3):605-612. doi: 10.1016/j.surg.2023.08.044. Epub 2023 Oct 31.
Surgery. 2024.
PMID: 37914572
Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy.
Tran CG, Borbon LC, Mudd JL, Abusada E, AghaAmiri S, Ghosh SC, Vargas SH, Li G, Beyer GV, McDonough M, Li R, Chan CHF, Walsh SA, Wadas TJ, O'Dorisio T, O'Dorisio MS, Govindan R, Cliften PF, Azhdarinia A, Bellizzi AM, Fields RC, Howe JR, Ear PH.
Tran CG, et al. Among authors: beyer gv.
Cancers (Basel). 2022 Apr 10;14(8):1910. doi: 10.3390/cancers14081910.
Cancers (Basel). 2022.
PMID: 35454817
Free PMC article.
Item in Clipboard
Cite
Cite